| Literature DB >> 31888109 |
Zhelun Zhang1,2, Luyao Tang1,2, Mengmeng Bao1,2, Zhigang Liu1,2, Wengong Yu1,2, Feng Han1,2.
Abstract
Alginate lyases degradeEntities:
Keywords: alginate lyase; brown algae; carbohydrate-binding module; enzymatic activity; enzymatic characterization; polysaccharide lyase; product distribution; thermostability
Mesh:
Substances:
Year: 2019 PMID: 31888109 PMCID: PMC7024181 DOI: 10.3390/md18010025
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 5.118
Figure 1Construction of FL TsAly7B and three truncated mutants. (A) Domain structure of FL TsAly7B and three truncated mutants. (B) SDS_PAGE showing the FL, TM1, TM2, and TM3 proteins. Lane M, marker. Lane 1, TsAly7B-FL. Lane 2, TM1. Lane 3, TM2. Lane 4, TM3.
Figure 2Effects of temperature and pH on the FL TsAly7B and three truncated mutants. Optimal temperature (A), optimal pH (B), thermal stability (C), and pH stability (D) of the FL TsAly7B and three truncated mutants. For optimal temperature (A) and optimal pH (B), the highest activity of each enzyme (11.7 U/mL) was set as 100%; for thermal stability (C), and pH stability (D), the original activity (15.1 U/mL) was set as 100%. Values represent the mean of three replicates ± standard deviation.
Figure 3Effects of NaCl concentration on the activity of the FL TsAly7B and three truncated mutants. The relative activity of 100% was determined at the optimal pH, temperature, and NaCl concentration.
Effects of reagents on activities of TsAly7B and truncated mutants.
| Reagents | Concentration | Relative Activity (%) | |||
|---|---|---|---|---|---|
| TsAly7B-FL | TsAly7B-TM1 | TsAly7B-TM2 | TsAly7B-TM3 | ||
| None | - | 100 | 100 | 100 | 100 |
| NH4Cl | 1 | 108.13 ± 3.56 | 102.04 ± 4.39 | 104.4 ± 12.19 | 102.31 ± 2.41 |
| LiCl | 1 | 105.58 ± 9.71 | 99.78 ± 4.37 | 77.14 ± 9.68 | 95.81 ± 9.31 |
| KCl | 1 | 104.28 ± 5.86 | 96.6 ± 3.53 | 107.47 ± 5.3 | 103.05 ± 2.94 |
| MgCl2 | 1 | 100.39 ± 2.37 | 100.7 ± 7.84 | 83.19 ± 3.92 | 100.57 ± 5.58 |
| CaCl2 | 1 | 114.36 ± 6.95 | 89.91 ± 12.71 | 100.82 ± 4.81 | 105.11 ± 10 |
| MnCl2 | 1 | 89.31 ± 7.92 | 93.31 ± 24.01 | 84.89 ± 3.58 | 50.47 ± 3.85 |
| BaCl2 | 1 | 91.29 ± 16.32 | 86.71 ± 10.09 | 50.34 ± 3.6 | 83.76 ± 7.6 |
| EDTA | 1 | 3.29 ± 0.58 | 1.1 ± 0.77 | 4.61 ± 3.59 | 2.26 ± 1.72 |
| SDS | 1 | 100.9 ± 3.19 | 89.86 ± 3.14 | 79.15 ± 3.94 | 90.24 ± 7.2 |
The relative activity of 100% was determined at optimal pH and temperature in the presence of 0.5 M NaCl.
The specific activity of TsAly7B and truncated mutants.
| Protein | Specific Activity | Molecular Weight | Specific Activity |
|---|---|---|---|
| TsAly7B-FL | 488.8 ± 12.4 | 64.79 | 31.6 ± 0.8 |
| TsAly7B-TM1 | 869.1 ± 9.1 | 51.35 | 44.6 ± 0.5 |
| TsAly7B-TM2 | 1147.2 ± 19.7 | 52.66 | 60.4 ± 1.0 |
| TsAly7B-TM3 | 238.4 ± 5.6 | 33.78 | 8.0 ± 0.2 |
Values were determined at the optimal pH and temperature in the presence of 0.5 M NaCl.
The substrate specificity of TsAly7B and truncated mutants.
| Relative Activity (%) | ||||
|---|---|---|---|---|
| Substrate | FL | TM1 | TM2 | TM3 |
| Alginate | 100 | 100 | 100 | 100 |
| PolyM | 110.93 ± 3.23 | 96.61 ± 12.46 | 97.08 ± 2.43 | 107.38 ± 28.33 |
| PolyG | 91.29 ± 4.6 | 81.47 ± 18.13 | 103.21 ± 5.81 | 43.05 ± 11.62 |
The relative activity of 100% was determined at optimal pH and temperature in the presence of 0.5 M NaCl.
Figure 4FPLC analysis of end products of the FL TsAly7B and three truncated mutants. Unsaturated disaccharides, trisaccharides, and tetrasaccharides were eluted at 34.2, 32.4, and 30.8 min, respectively. The mixture of unsaturated disaccharides, trisaccharides, and tetrasaccharides was used as the marker, and the total uronic acid concentration was 0.2% (w/v).
Primers used in this study.
| Primers | Sequence (5′ to 3′) | Usage |
|---|---|---|
| Expression of TsAly7B and truncated proteins | ||
| TsAly7B-FL-F | CATG | Expression of TsAly7B-FL |
| TsAly7B-FL-R | CCG | |
| TsAly7B-TM1-F | CATG | Expression of TsAly7B-TM1 |
| TsAly7B-TM1-R | CCG | |
| TsAly7B-TM2-1-F | CATG | Expression of TsAly7B-TM2 |
| TsAly7B-TM2-1-R | CG | |
| TsAly7B-TM2-2-F | CG | |
| TsAly7B-TM2-2-R | CCG | |
| TsAly7B-TM3-F | CATG | Expression of TsAly7B-TM3 |
| TsAly7B-TM3-R | CCG | |